Delayed coloanal anastomosis: an alternative option for restorative rectal cancer surgery after high-dose pelvic radiotherapy for prostate cancer.


Journal

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611

Informations de publication

Date de publication:
11 2020
Historique:
received: 02 09 2019
accepted: 27 03 2020
pubmed: 29 5 2020
medline: 19 8 2021
entrez: 29 5 2020
Statut: ppublish

Résumé

Restorative total mesorectal excision (TME) for rectal cancer after high-dose pelvic radiotherapy for prostate cancer has been reported to provide an unacceptable rate of pelvic sepsis. In a previous publication we proposed that delayed coloanal anastomosis (DCAA) should be performed in this situation. The present study aimed to assess the feasibility and outcomes of this strategy. Between 2000 and 2018, 1094 men were operated on for rectal cancer in our institution. All men with T2/T3 mid and low rectal cancer with preoperative radiotherapy and restorative TME were considered for this study (n = 416). Patients with external-beam high-dose radiotherapy (EBHRT) for prostate cancer (70-78 Gy) were identified and compared with patients with conventional long-course chemoradiotherapy (CRT) followed by TME. We compared our already published historical cohort (2000-2012), including arm A (CRT + TME; n = 236) and arm B (EBHRT + TME; n = 12), with our early cohort (2013-2018), including arm C (CRT + TME; n = 158) and arm D (EBHRT + TME-DCAA; n = 10). The end-points were morbidity, pelvic sepsis, reoperation rate and quality of the specimen. Overall morbidity was not significantly different between groups. Pelvic sepsis decreased from 50% (arm B) to 10% (arm D) with the use of DCAA (P = 0.074), and was similar between arms A, C and D. Quality of the specimen was not significantly different between the four groups. Our results suggest that TME with DCAA in patients with previous EBHRT is feasible, with the same postoperative pelvic sepsis rate as conventional CRT.

Identifiants

pubmed: 32463973
doi: 10.1111/codi.15144
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1545-1552

Informations de copyright

Colorectal Disease © 2020 The Association of Coloproctology of Great Britain and Ireland.

Références

Buscail E, Blondeau V, Adam J-P et al. Surgery for rectal cancer after high-dose radiotherapy for prostate cancer: is sphincter preservation relevant? Colorectal Dis 2015; 17: 973-9.
Guandalino M, Dupré A, François M et al. Previous radiation for prostate neoplasm alters surgical and oncologic outcomes after rectal cancer surgery. J Surg Oncol 2015; 112: 802-8.
Lakkis Z, Vernerey D, Mege D et al. Morbidity and oncological outcomes of rectal cancer impaired by previous prostate malignancy. Br J Surg 2019; 106: 1087-98.
Walker KG, Bell SW, Rickard MJFX et al. Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer. Ann Surg 2004; 240: 255-9.
Bell SW, Walker KG, Rickard MJFX et al. Anastomotic leakage after curative anterior resection results in a higher prevalence of local recurrence. Br J Surg 2003; 90: 1261-6.
Hain E, Maggiori L, Manceau G, Mongin C, Prost à la Denise J, Panis Y. Oncological impact of anastomotic leakage after laparoscopic mesorectal excision. Br J Surg 2017; 104: 288-95.
Babcock WW. William Wayne Babcock 1872-1963. The Operative treatment of carcinoma of the rectosigmoid with methods for the elimination of colostomy. Dis Colon Rectum 1989; 32: 442-7.
Baulieux J, Olagne E, Ducerf C et al. [Oncologic and functional results of resections with direct delayed coloanal anastomosis in previously irradiated cancers of the lower rectum]. Chir Memoires Acad Chir 1999; 124: 240-50; discussion 251.
Turnbull RB. Pull-through resection of the rectum, with delayed anastomosis, for cancer or Hirschsprung’s disease. Surgery 1966; 59: 498-502.
Cutait DE, Figliolini FJ. A new method of colorectal anastomosis in abdominoperineal resection. Dis Colon Rectum 1961; 4: 335-42.
Remzi FH, El Gazzaz G, Kiran RP, Kirat HT, Fazio VW. Outcomes following Turnbull-Cutait abdominoperineal pull-through compared with coloanal anastomosis. Br J Surg 2009; 96: 424-9.
Hallet J, Milot H, Drolet S, Desrosiers E, Grégoire RC, Bouchard A. The clinical results of the Turnbull-Cutait delayed coloanal anastomosis: a systematic review. Tech Coloproctol 2014; 18: 579-90.
Boullenois H, Lefevre JH, Creavin B et al. What is the functional result of a delayed coloanal anastomosis in redo rectal surgery? ANZ J Surg 2019; 89: E179-E183.
Maggiori L, Blanche J, Harnoy Y, Ferron M, Panis Y. Redo-surgery by transanal colonic pull-through for failed anastomosis associated with chronic pelvic sepsis or rectovaginal fistula. Int J Colorectal Dis 2015; 30: 543-8.
Gérard J-P, André T, Bibeau F et al. Rectal cancer: French Intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO). Dig Liver Dis 2017; 49: 359-67.
Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-13.
Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum 1993; 36: 77-97.
Emmertsen KJ, Laurberg S. Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg 2012; 255: 922-8.
Didailler R, Denost Q, Loughlin P et al. Antegrade enema after total mesorectal excision for rectal cancer: the last chance to avoid definitive colostomy for refractory low anterior resection syndrome and fecal incontinence. Dis Colon Rectum 2018; 61: 667-72.
Denost Q, Rouanet P, Faucheron J-L et al. To drain or not to drain infraperitoneal anastomosis after rectal excision for cancer: the GRECCAR 5 randomized trial. Ann Surg 2017; 265: 474-80.
Jarry J, Faucheron JL, Moreno W, Bellera CA, Evrard S. Delayed colo-anal anastomosis is an alternative to prophylactic diverting stoma after total mesorectal excision for middle and low rectal carcinomas. Eur J Surg Oncol 2011; 37: 127-33.
Lefevre JH, Mineur L, Kotti S et al. Effect of Interval (7 or 11 weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer: a multicenter, randomized, controlled trial (GRECCAR-6). J Clin Oncol 2016; 34: 3773-80.
Olagne E, Baulieux J, de la Roche E et al. Functional results of delayed coloanal anastomosis after preoperative radiotherapy for lower third rectal cancer. J Am Coll Surg 2000; 191: 643-9.
Sage P-Y, Trilling B, Waroquet P-A, Voirin D, Girard E, Faucheron J-L. Laparoscopic delayed coloanal anastomosis without diverting ileostomy for low rectal cancer surgery: 85 consecutive patients from a single institution. Tech Coloproctol 2018; 22: 511-8.
Portale G, Popesc GO, Parotto M, Cavallin F. Delayed colo-anal anastomosis for rectal cancer: pelvic morbidity, functional results and oncological outcomes: a systematic review. World J Surg 2019; 43: 1360-9.

Auteurs

M-O François (MO)

Department of Digestive Surgery, CHU de Bordeaux, Haut-Lévêque Hospital, Pessac, France.

E Buscail (E)

Department of Digestive Surgery, CHU de Bordeaux, Haut-Lévêque Hospital, Pessac, France.

V Vendrely (V)

Department of Radiotherapy, CHU de Bordeaux, Haut-Lévêque Hospital, Pessac, France.

B Célérier (B)

Department of Digestive Surgery, CHU de Bordeaux, Haut-Lévêque Hospital, Pessac, France.

V Assénat (V)

Department of Digestive Surgery, CHU de Bordeaux, Haut-Lévêque Hospital, Pessac, France.

J-B Moreau (JB)

Department of Digestive Surgery, CHU de Bordeaux, Haut-Lévêque Hospital, Pessac, France.

E Rullier (E)

Department of Digestive Surgery, CHU de Bordeaux, Haut-Lévêque Hospital, Pessac, France.

Q Denost (Q)

Department of Digestive Surgery, CHU de Bordeaux, Haut-Lévêque Hospital, Pessac, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH